Baird initiated coverage of Alignment Healthcare with an Outperform rating and $10 price target. The firm started coverage on nine Managed Care companies with six having Outperform ratings and three having Neutral ratings. Baird believes Managed Care is structurally well positioned to drive sustainably attractive long-term growth, margin expansion and multiple expansion beyond historical levels, despite recent volatility in Medicare Advantage that may continue to keep Medicare Advantage multiples depressed over the coming year, the analyst tells investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALHC:
- Alignment Healthcare to Present at William Blair’s 44th Annual Growth Stock Conference
- Piper Sandler upgrades Alignment Healthcare to Overweight on strong resuts
- Alignment Healthcare upgraded to Overweight from Neutral at Piper Sandler
- Alignment Healthcare price target raised to $7 from $6 at Stephens
- Alignment Healthcare reports Q1 EPS (25c), consensus (22c)